Cornucopian Capital Management — 2026 Investments
2 investments dated 2026 · listed companies and verified rows first · show all
Caffree develops a powdered enzymatic system for precision decaffeination that converts caffeine into theobromine, allowing coffee brands to control caffeine levels without changing flavor.
BiotechDeep TechFoodTechSeattle, US
Eric Steven Quick(Executive Officer, Director)Aryeh Ganz(Executive Officer, Director, Promoter)
BoardFrank Curzio(Director)
Co-investorsBaruch Future Ventures
Claymont, US
Elina Onitskansky(Executive Officer, Director, Promoter)
BoardAryeh Ganz(Director)Matthew Klitus(Director)
Co-investorsCity LightLifeX VenturesPeakBridge VC
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.